Psoriasis Flashcards
treatment of recalcitrant psoriatic arthritis
methotrexate and TNF alpha inhibitor
helps slow progression of radiographic damage including joint space narrowing and erosions
second line drug for psoriatic arthritis
if already taking methotrexate at 25 mg weekly, add a TNF alpha inhibitor
Do we ever use hydroxychloroquine in psoriasis treatment
no.
hydroxychloroquine is for SLE or RA or dermatomyositis.
Do we ever use rituximab for psoriasis?
No it’s for RA, vasculitis and malignancy
it’s holy water of oncology
clinical features of psoriatic arthritis
distal interphalangeal joints, asymmetric oligoarthritis
symmetrical polyarthritis, similar to RA
arthritis mutilans (deforming and destructive arthritis)
spondyloarthritides (sacroiliitis and spondylitis)
soft tissue and nail involvement seen with psoriatic arthritis?
enthesitis (inflammation at the site of tendon insertion into bone)
dactylitis “sausage digits of toe or finger
swelling of hands or feet with pitting edema
skin lesions seen with psoriatic arthritis
arthritis that precedes skin disease in 15% of pts
skin lesions are present but not yet diagnosed in 15% of pts.
Hand XR pf a patient with psoriasis show
erosive changes with new bone formation, lysis at the terminal phalanges and joint destruction and pencil-in-cup appearance and joint lysis with ankylosis.
destructive arthritis mutilans and pencil cup appearnce and pitting of nails and onycholysis may point to
psoriasis.
hemochromatosis may have arthritis and see on physical exam and XR
see MCP joints and see distribution similar to pseudogout with (calcium pyrophosphate crystal deposition)
See chondrocalcinosis and hooked osteophytes in MCP
treatment of mild to moderate plaque psoriasis is
topical corticosteroids and emollients
tar, topical retinoids, and topical vitamin D (Calcipotriene and calcitoriol)
most common form of psoriasis
plaque psoriasis - sharply demarcated erythematous plaques over a thick silvery scale
treatment of plaque psoriasis is
based on severity of disease, sites of involvement, relevant comorbidities, pt preference, efficiency and patient response
treatment of facial or intertriginous plaque psoriasis
topical tacrolimus or pimecrolimus as a steroid sparing agent as chronic steroid cream to the face or skin folds can cause harm effects like atrophy, telangiectasia and perioral dermatitis.
moderate to severe plaque psoriasis treatment
needs dermatologist but will need phototherapy.